152 related articles for article (PubMed ID: 16767910)
1. Radionuclide therapy with bone seeking radionuclides in palliation of painful bone metastases.
Maini CL; Sciuto R; Romano L; Bergomi S
J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):71-4. PubMed ID: 16767910
[TBL] [Abstract][Full Text] [Related]
2. Radiopharmaceuticals for Palliation of Bone Pain in Patients with Castration-resistant Prostate Cancer Metastatic to Bone: A Systematic Review.
Jong JM; Oprea-Lager DE; Hooft L; de Klerk JM; Bloemendal HJ; Verheul HM; Hoekstra OS; van den Eertwegh AJ
Eur Urol; 2016 Sep; 70(3):416-26. PubMed ID: 26391636
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of 188Re-HEDP, 186Re-HEDP, 153Sm-EDTMP and 89Sr in the treatment of painful skeletal metastases.
Liepe K; Kotzerke J
Nucl Med Commun; 2007 Aug; 28(8):623-30. PubMed ID: 17625384
[TBL] [Abstract][Full Text] [Related]
4. Strontium 89 therapy for the palliation of pain due to osseous metastases.
Robinson RG; Preston DF; Schiefelbein M; Baxter KG
JAMA; 1995 Aug; 274(5):420-4. PubMed ID: 7542352
[TBL] [Abstract][Full Text] [Related]
5. [Radionuclide therapy for painful bone metastases].
Szefer J; Zuchora Z
Wiad Lek; 2004; 57(5-6):280-3. PubMed ID: 15518077
[TBL] [Abstract][Full Text] [Related]
6. Radionuclide therapy and integrated protocols for bone metastases.
Chiacchio S; Mazzarri S; Lorenzoni A; Nyakale N; Boni G; Borsò E; Alsharif A; Grosso M; Manca G; Greco C; Volterrani D; Mariani G
Q J Nucl Med Mol Imaging; 2011 Aug; 55(4):431-47. PubMed ID: 21738116
[TBL] [Abstract][Full Text] [Related]
7. Radiopharmaceutical therapy of bone metastases with 89SrCl2, 186Re-HEDP and 153Sm-EDTMP: a dosimetric study using Monte Carlo simulation.
Strigari L; Sciuto R; D'Andrea M; Pasqualoni R; Benassi M; Maini CL
Eur J Nucl Med Mol Imaging; 2007 Jul; 34(7):1031-8. PubMed ID: 17237963
[TBL] [Abstract][Full Text] [Related]
8. Our experience on pain palliation of bone metastasis with Sr-89 or Sm-153 in cancer patients resistant to a conventional analgesic therapy. A retrospective study.
Montesano T; Giacomobono S; Acqualagna G; Colandrea M; Di Nicola A; Travascio L; Giancamerla M; D'Apollo R; Toteda M; Ugolini F; Filesi M; Ronga G
Clin Ter; 2009; 160(3):193-9. PubMed ID: 19756320
[TBL] [Abstract][Full Text] [Related]
9. Impact of ¹⁸F-fluoride PET-CT on implementing early treatment of painful bone metastases with Sm-153 EDTMP.
Storto G; Gallicchio R; Pellegrino T; Nardelli A; De Luca S; Capacchione D; Sirignano C; Pace L
Nucl Med Biol; 2013 May; 40(4):518-23. PubMed ID: 23522973
[TBL] [Abstract][Full Text] [Related]
10. Unsealed source therapy of painful bone metastases: an update.
McEwan AJ
Semin Nucl Med; 1997 Apr; 27(2):165-82. PubMed ID: 9144858
[TBL] [Abstract][Full Text] [Related]
11. 89Sr versus 153Sm-EDTMP: comparison of treatment efficacy of painful bone metastases in prostate and breast carcinoma.
Baczyk M; Czepczyński R; Milecki P; Pisarek M; Oleksa R; Sowiński J
Nucl Med Commun; 2007 Apr; 28(4):245-50. PubMed ID: 17325585
[TBL] [Abstract][Full Text] [Related]
12. A multicentre observational study of radionuclide therapy in patients with painful bone metastases of prostate cancer.
Dafermou A; Colamussi P; Giganti M; Cittanti C; Bestagno M; Piffanelli A
Eur J Nucl Med; 2001 Jul; 28(7):788-98. PubMed ID: 11504074
[TBL] [Abstract][Full Text] [Related]
13. Radionuclide therapy for painful bone metastases. An Italian multicentre observational study. Writing Committee of an Ad Hoc Study Group.
Piffanelli A; Dafermou A; Giganti M; Colamussi P; Pizzocaro C; Bestagno M;
Q J Nucl Med; 2001 Mar; 45(1):100-7. PubMed ID: 11456368
[TBL] [Abstract][Full Text] [Related]
14. Pain palliation and nuclear medicine.
McEwan AJ
Eur J Nucl Med; 1993 Jan; 20(1):1-3. PubMed ID: 7678395
[No Abstract] [Full Text] [Related]
15. (153)Sm-EDTMP for pain relief of bone metastases from prostate and breast cancer and other malignancies.
Correa-González L; Arteaga de Murphy C; Pichardo-Romero P; Pedraza-López M; Moreno-García C; Correa-Hernández L
Arch Med Res; 2014 May; 45(4):301-8. PubMed ID: 24681187
[TBL] [Abstract][Full Text] [Related]
16. 186Re-etidronate. Efficacy of palliative radionuclide therapy for painful bone metastases.
Han SH; De Klerk JM; Zonnenberg BA; Tan S; Van Rijk PP
Q J Nucl Med; 2001 Mar; 45(1):84-90. PubMed ID: 11456380
[TBL] [Abstract][Full Text] [Related]
17. Bone seeking radiopharmaceuticals for palliation of pain in cancer patients with osseous metastases.
Lam MG; de Klerk JM; van Rijk PP; Zonnenberg BA
Anticancer Agents Med Chem; 2007 Jul; 7(4):381-97. PubMed ID: 17630915
[TBL] [Abstract][Full Text] [Related]
18. EANM procedure guidelines for treatment of refractory metastatic bone pain.
Silberstein EB; Taylor AT;
Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):BP7-11. PubMed ID: 12723557
[No Abstract] [Full Text] [Related]
19. Advances in our understanding of the treatment of painful bone metastasis.
Siberstein EB
J Nucl Med; 2000 Apr; 41(4):655-7. PubMed ID: 10809605
[No Abstract] [Full Text] [Related]
20. Bench to bedside development of GMP grade Rhenium-188-HEDP, a radiopharmaceutical for targeted treatment of painful bone metastases.
ter Heine R; Lange R; Breukels OB; Bloemendal HJ; Rummenie RG; Wakker AM; de Graaf H; Beekman FJ; van der Westerlaken MM; Malingré MM; Wielders JP; van den Berg L; Hendrikse NH; de Klerk JM
Int J Pharm; 2014 Apr; 465(1-2):317-24. PubMed ID: 24560635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
